首页|系统性炎症指标在哮喘-慢阻肺重叠鉴别诊断中的运用价值

系统性炎症指标在哮喘-慢阻肺重叠鉴别诊断中的运用价值

扫码查看
目的 分析系统性炎症指标在哮喘-慢阻肺重叠中的诊断价值.方法 选取2021年1月-2022年12月本院收治的247例慢性呼吸道疾病患者,根据临床诊断分为ACO组(88例),Asthma组(75例),COPD组(84例),比较3组患者基线资料及系统性炎症指标的差异.通过受试者工作特征曲线评价各指标对ACO的鉴别效能.结果 3组患者NLR、PLR、LMR、SII 及 SIRI 间的差异均有统计学意义(P<0.05).NLR>3.420、PLR>162.17、SII>772.26、SIRI>1.475、LMR<2.645五个指标联合诊断Asthma与ACO的ROC曲线下面积为0.758(95%CI:0.682~0.833,P<0.05),具有较好的诊断效能.结论 COPD、Asthma与ACO 3组患者的NLR、PLR、LMR、SII、SIRI等系统性炎症指标分布有差异,且与其肺功能指标存在一定的相关性.联合运用5个指标对于Asthma与ACO的鉴别有一定的诊断价值.
Application value of systemic inflammatory index in the differential diagnosis of asthma-COPD overlap
Objective To analyze the diagnostic value of systemic inflammatory index in asthma-COPD overlap.Methods A total of 247 patients with chronic respiratory diseases were admitted to our hospital from January 2021 to December 2022,they were divided into ACO group(88 cases),Asthma group(75 cases)and COPD group(84 cases)according to clinical diagnosis.The differences of baseline data and systemic inflammation indexes among the three groups were compared.The identification efficiency of each index to ACO was evaluated by subject operating characteristic curve.Results The differences of NLR,PLR,LMR,SII and SIRI among the three groups were statistically significant(P<0.05).The area under ROC curve of five indexes with NLR>3.420,PLR>162.17,SII>772.26,SIRI>1.475,LMR<2.645,EBR<1.38 for combined diagnosis Asthma and ACO was 0.758(95%CI:0.682~0.833,P<0.05),which had good diagnostic efficacy.Conclusions There are differences in the distribution of systemic inflammatory indicators such as NLR,PLR,LMR,SII and SIRI in COPD,Asthma and ACO groups,and there is a certain correlation with their pulmonary function indicators.The combined application of 5 indexes has certain diagnostic value for the identification of Asthma and ACO.

systemic inflammatory markersasthma-COPD overlapdifferential diagnosis

李颖、李胡焕、李春梅、杨宇溪、徐文波、尹皓原

展开 >

玉溪市人民医院/昆明医科大学第六附属医院医学检验科,云南 玉溪 653100

玉溪市人民医院/昆明医科大学第六附属医院胸外科,云南 玉溪 653100

系统性炎症指标 哮喘-慢阻肺重叠 鉴别诊断

国家自然科学基金云南省教育厅科学研究基金项目

821604022022J0203

2024

云南医药
中华医学会云南分会

云南医药

影响因子:0.459
ISSN:1006-4141
年,卷(期):2024.45(4)
  • 4